Your browser doesn't support javascript.
loading
Pharmacokinetics of Pyrazinamide and Optimal Dosing Regimens for Drug-Sensitive and -Resistant Tuberculosis.
Chirehwa, Maxwell T; McIlleron, Helen; Rustomjee, Roxana; Mthiyane, Thuli; Onyebujoh, Philip; Smith, Peter; Denti, Paolo.
Affiliation
  • Chirehwa MT; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • McIlleron H; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Rustomjee R; Strategic Health Innovation Partnerships (SHIP), South African Medical Research Council, Cape Town, South Africa.
  • Mthiyane T; TB Research Unit, Clinical and Biomedical, South African Medical Research Council, Durban, South Africa.
  • Onyebujoh P; Intercountry Support Team for East and Southern Africa, World Health Organization, Regional Office for Africa, Harare, Zimbabwe.
  • Smith P; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Denti P; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa paolo.denti@uct.ac.za.
Article in En | MEDLINE | ID: mdl-28607022

Full text: 1 Database: MEDLINE Main subject: Pyrazinamide / Rifampin / Tuberculosis, Pulmonary / HIV Infections / Tuberculosis, Multidrug-Resistant / Ethambutol / Isoniazid / Antitubercular Agents Type of study: Diagnostic_studies / Guideline / Prognostic_studies Limits: Adolescent / Adult / Humans / Male / Middle aged Language: En Year: 2017 Type: Article

Full text: 1 Database: MEDLINE Main subject: Pyrazinamide / Rifampin / Tuberculosis, Pulmonary / HIV Infections / Tuberculosis, Multidrug-Resistant / Ethambutol / Isoniazid / Antitubercular Agents Type of study: Diagnostic_studies / Guideline / Prognostic_studies Limits: Adolescent / Adult / Humans / Male / Middle aged Language: En Year: 2017 Type: Article